Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Intervalo de año de publicación
1.
Trends Psychiatry Psychother ; 39(1): 43-47, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28403322

RESUMEN

INTRODUCTION:: Transsexualism (ICD-10) is a condition characterized by a strong and persistent dissociation with one's assigned gender. Sex reassignment surgery (SRS) and hormone therapy provide a means of allowing transsexual individuals to feel more congruent with their gender and have played a major role in treatment over the past 70 years. Brain-derived neurotrophic factor (BDNF) appears to play a key role in recovery from acute surgical trauma and environmentally mediated vulnerability to psychopathology. We hypothesize that BDNF may be a biomarker of alleviation of gender incongruence suffering. OBJECTIVES:: To measure preoperative and postoperative serum BDNF levels in transsexual individuals as a biomarker of alleviation of stress related to gender incongruence after SRS. METHODS:: Thirty-two male-to-female transsexual people who underwent both surgery and hormonal treatment were selected from our initial sample. BDNF serum levels were assessed before and after SRS with sandwich enzyme linked immunosorbent assay (ELISA). The time elapsed between the pre-SRS and post-SRS blood collections was also measured. RESULTS:: No significant difference was found in pre-SRS or post-SRS BDNF levels or with relation to the time elapsed after SRS when BDNF levels were measured. CONCLUSION:: Alleviation of the suffering related to gender incongruence after SRS cannot be assessed by BDNF alone. Surgical solutions may not provide a quick fix for psychological distress associated with transsexualism and SRS may serve as one step toward, rather than as the conclusion of, construction of a person's gender identity.


Asunto(s)
Factor Neurotrófico Derivado del Encéfalo/sangre , Disforia de Género/sangre , Cirugía de Reasignación de Sexo , Estrés Psicológico/sangre , Transexualidad/sangre , Adulto , Biomarcadores/sangre , Análisis Químico de la Sangre , Ensayo de Inmunoadsorción Enzimática , Femenino , Disforia de Género/tratamiento farmacológico , Disforia de Género/psicología , Disforia de Género/cirugía , Infecciones por VIH/sangre , Infecciones por VIH/complicaciones , Terapia de Reemplazo de Hormonas , Humanos , Masculino , Periodo Posoperatorio , Periodo Preoperatorio , Estudios Prospectivos , Estrés Psicológico/etiología , Personas Transgénero/psicología , Transexualidad/tratamiento farmacológico , Transexualidad/psicología , Transexualidad/cirugía , Resultado del Tratamiento
2.
Trends psychiatry psychother. (Impr.) ; 39(1): 43-47, Jan.-Mar. 2017. graf
Artículo en Inglés | LILACS | ID: biblio-846398

RESUMEN

Abstract Introduction: Transsexualism (ICD-10) is a condition characterized by a strong and persistent dissociation with one's assigned gender. Sex reassignment surgery (SRS) and hormone therapy provide a means of allowing transsexual individuals to feel more congruent with their gender and have played a major role in treatment over the past 70 years. Brain-derived neurotrophic factor (BDNF) appears to play a key role in recovery from acute surgical trauma and environmentally mediated vulnerability to psychopathology. We hypothesize that BDNF may be a biomarker of alleviation of gender incongruence suffering. Objectives: To measure preoperative and postoperative serum BDNF levels in transsexual individuals as a biomarker of alleviation of stress related to gender incongruence after SRS. Methods: Thirty-two male-to-female transsexual people who underwent both surgery and hormonal treatment were selected from our initial sample. BDNF serum levels were assessed before and after SRS with sandwich enzyme linked immunosorbent assay (ELISA). The time elapsed between the pre-SRS and post-SRS blood collections was also measured. Results: No significant difference was found in pre-SRS or post-SRS BDNF levels or with relation to the time elapsed after SRS when BDNF levels were measured. Conclusion: Alleviation of the suffering related to gender incongruence after SRS cannot be assessed by BDNF alone. Surgical solutions may not provide a quick fix for psychological distress associated with transsexualism and SRS may serve as one step toward, rather than as the conclusion of, construction of a person's gender identity.


Resumo Introdução: O transexualismo (CID-10) é uma condição caracterizada por forte e persistente dissociação com o gênero atribuído. A cirurgia de redesignação sexual (CRS) e a terapia hormonal (TH) permitem que indivíduos transexuais se sintam mais congruentes com seu gênero e, por isso, têm desempenhado papel importante nos últimos 70 anos. O fator neurotrófico derivado do cérebro (BDNF) parece desempenhar um papel fundamental na recuperação do trauma cirúrgico agudo e vulnerabilidade ambiental à psicopatologia. Nós hipotetizamos que o BDNF pode ser um biomarcador de alívio do sofrimento de incongruência de gênero pós-CRS. Objetivos: Mensurar os níveis séricos de BDNF no pré e pós-operatório em indivíduos transexuais como biomarcador de alívio de estresse relacionado à incongruência de gênero após a CRS. Métodos: Trinta e duas pessoas transexuais masculino para feminino submetidas a cirurgia e tratamento hormonal foram selecionadas de nossa amostra inicial. O nível sérico de BDNF foi avaliado antes e depois da CRS pela técnica ELISA. O tempo decorrido entre as coletas de sangue pré e pós-CRS foi medido. Resultados: Não houve diferença significativa nos níveis de BDNF pré e pós-CRS ou em relação ao tempo decorrido entre a CRS e a coleta. Conclusão: O alívio do sofrimento relacionado à incongruência de gênero pós-CRS não pode ser avaliado apenas pelo BDNF. Soluções cirúrgicas podem não fornecer uma solução rápida para o sofrimento associado ao transexualismo, e a CRS pode servir como um passo em direção à, em vez de conclusão da, construção da identidade de gênero de uma pessoa.


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Estrés Psicológico/sangre , Transexualidad/sangre , Factor Neurotrófico Derivado del Encéfalo/sangre , Cirugía de Reasignación de Sexo , Disforia de Género/sangre , Periodo Posoperatorio , Transexualidad/cirugía , Transexualidad/psicología , Transexualidad/tratamiento farmacológico , Análisis Químico de la Sangre , Ensayo de Inmunoadsorción Enzimática , Biomarcadores/sangre , Infecciones por VIH/complicaciones , Infecciones por VIH/sangre , Estudios Prospectivos , Resultado del Tratamiento , Terapia de Reemplazo de Hormonas , Periodo Preoperatorio , Disforia de Género/cirugía , Disforia de Género/psicología , Disforia de Género/tratamiento farmacológico
5.
J Psychiatr Res ; 47(10): 1546-8, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23702250

RESUMEN

Gender Identity Disorder (GID) is characterized by a strong and persistent cross-gender identification that affects different aspects of behavior. Brain-derived neurotrophic factor (BDNF) plays a critical role in neurodevelopment and neuroplasticity. Altered BDNF-signaling is thought to contribute to the pathogenesis of psychiatric disordersand is related to traumatic life events. To examine serum BDNF levels, we compared one group of DSM-IV GID patients (n = 45) and one healthy control group (n = 66). Serum BDNF levels were significantly decreased in GID patients (p = 0.013). This data support the hypothesis that the reduction found in serum BDNF levels in GID patients may be related to the psychological abuse that transsexuals are exposed during their life.


Asunto(s)
Factor Neurotrófico Derivado del Encéfalo/sangre , Identidad de Género , Transexualidad/sangre , Adulto , Femenino , Humanos , Masculino , Escalas de Valoración Psiquiátrica , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...